An immunoassay drug screen does not tell you that a substance is present. It tells you that something in the sample bound to an antibody in a way consistent with that substance. Those are different statements, and the gap between them has consequences.
How often this matters
A review of 173 articles, condensed to 62 containing false-positive data from 2000 onward, tabulated documented immunoassay false positives across amphetamines, opiates, benzodiazepines, cannabinoids, tricyclic antidepressants, phencyclidine, LSD and barbiturates. Its conclusion is the operational rule: immunoassay positives “are considered presumptive until confirmed by a second independent chemical technique.”
A case that shows the stakes
A published case series describes three pregnant or postpartum patients who began labetalol — an ordinary antihypertensive in pregnancy — and produced presumptive-positive fentanyl immunoassay results.
Consider what an unconfirmed fentanyl positive triggers in a pregnancy. Child protective reporting. A birth plan changed. A relationship with a clinical team damaged in a way that does not repair. All from a blood pressure medication and a screening assay behaving exactly as documented.
And the people reading them often cannot
A survey of 911 clinical and laboratory professionals across the US and Canada tested interpretation with six questions. Toxicologists averaged 4.82 out of 6 and laboratory PhDs 4.63. Physicians in pathology, emergency medicine, primary care and internal medicine “displayed concerning knowledge gaps,” largest in identifying simulated compliance, opioid metabolism and cross-reactivity. More than 30% said they would seek interpretation guidance from the internet or from peers rather than from a laboratory expert.
So the failure is not one thing. It is a presumptive result, acted on by someone without the training to read it, in a setting where the consequence for the patient is severe and hard to reverse.
The rules that follow
- Confirm before acting. Always. This single rule prevents most of the documented harm.
- Never let a presumptive result leave the laboratory looking like a finding. If a display shows presumptive and confirmed results the same way, the display is the defect.
- Return results with interpretation, and give the ordering clinician a route to someone competent to explain them.
- Do not dismiss anyone on a test result. CDC states this directly, and it applies with particular force to unconfirmed ones.
- Know whose sample it is. Chain of custody is the other half — see custodial toxicology.
More: the urine drug testing evidence.
Sources
Every figure on this page is traceable to the source listed here.
- Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387–396. PMID 24986836. View source.
- Wanar A, Isley BC, Saia K, Field TA. False-positive fentanyl urine detection after initiation of labetalol treatment for hypertension in pregnancy: a case report. J Addict Med. 2022;16(6):e417–e419. PMID 35972891. View source.
- Snozek CLH, Yee CI, Bryksin J, et al. Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals. Am J Clin Pathol. 2025;163(1):69–79. PMID 39066575. View source.
- Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain — United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. PMID 36327391. View source.